Cannabis Bioscience International Holdings, Inc. Stock

Equities

CBIH

US16948K1060

Biotechnology & Medical Research

Market Closed - OTC Markets 03:35:53 2024-04-26 pm EDT 5-day change 1st Jan Change
0.00065 USD +8.33% Intraday chart for Cannabis Bioscience International Holdings, Inc. +16.67% -12.50%
Sales 2022 215K Sales 2023 317K Capitalization 5.02M
Net income 2022 - Net income 2023 -1M EV / Sales 2022 63.8 x
Net Debt 2022 355K Net Debt 2023 381K EV / Sales 2023 17 x
P/E ratio 2022
-14.2 x
P/E ratio 2023
-4.39 x
Employees 2
Yield 2022 *
-
Yield 2023
-
Free-Float 60.1%
More Fundamentals * Assessed data
Dynamic Chart
1 day+8.33%
1 week+16.67%
Current month-12.50%
1 month-12.50%
3 months+16.67%
6 months+40.00%
Current year-12.50%
More quotes
1 week
0.00
Extreme 0.0005
0.00
1 month
0.00
Extreme 0.0005
0.00
Current year
0.00
Extreme 0.0004
0.00
1 year
0.00
Extreme 0.0003
0.00
3 years
0.00
Extreme 0.0003
0.01
5 years
0.00
Extreme 0
0.01
10 years
0.00
Extreme 0
0.27
More quotes
Managers TitleAgeSince
Chief Executive Officer 68 19-12-18
Director/Board Member 65 19-12-18
Director/Board Member 72 19-12-18
Members of the board TitleAgeSince
Director/Board Member 72 19-12-18
Chief Executive Officer 68 19-12-18
Director/Board Member 65 19-12-18
More insiders
Date Price Change Volume
24-04-26 0.00065 +8.33% 46,493
24-04-25 0.0006 +20.00% 1,277,736
24-04-24 0.0005 0.00% 166,000
24-04-23 0.0005 -16.67% 1,764,333
24-04-22 0.0006 0.00% 274,613

Delayed Quote OTC Markets, April 26, 2024 at 03:35 pm EDT

More quotes
Cannabis Bioscience International Holdings, Inc. provides educational and other services to the cannabis industry. The Company provides educational systems focused on medical cannabis in cities throughout the United States and six countries in Latin America. The Company’s segments include Pharmacology University Business and Alpha Research Business. Through the Pharmacology University Business, the Company provides knowledge and promotes professionalism in the rapidly growing worldwide cannabis industry through education in and research about the medical properties and healing virtues of this substance. Through the Alpha Research Business, based in Houston, Texas, the Company offers specialized services in all therapeutic areas of clinical trials and has conducted over 20 clinical trials for Sponsors and CROs. These trials have included drugs relating to diseases in the areas of asthma, allergies, renal disorders, neurology disorders, cardiac and vascular disorders and others.
More about the company